HSPA5 and malignant colon neoplasm: Likewise, down-regulation of secretory HSPA5/GRP78 protein emerged in our study as a significant feature associated with chemoresistant phenotype, which was also found in in silico analyses to be correlated with BRAFV600E genotype and poor survival rates in colon cancer patients.